{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:33:52Z","timestamp":1774787632945,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T00:00:00Z","timestamp":1453075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008509","name":"Open University (GB)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008509","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12017-016-8384-z","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T01:59:17Z","timestamp":1453082357000},"page":"146-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington\u2019s Disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Glenn M.","family":"Dall\u00e9rac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian M.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austen J.","family":"Milnerwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry P. S. J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,18]]},"reference":[{"issue":"16","key":"8384_CR1","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0047-6374(01)00317-7","volume":"122","author":"F Amenta","year":"2001","unstructured":"Amenta, F., Mignini, F., Ricci, A., Sabbatini, M., Tomassoni, D., & Tayebati, S. K. (2001). Age-related changes of dopamine receptors in the rat hippocampus: A light microscope autoradiography study. Mechanisms of Ageing and Development, 122(16), 2071\u20132083.","journal-title":"Mechanisms of Ageing and Development"},{"issue":"3","key":"8384_CR2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","volume":"16","author":"VM Andr\u00e9","year":"2010","unstructured":"Andr\u00e9, V. M., Cepeda, C., & Levine, M. S. (2010). Dopamine and glutamate in Huntington\u2019s disease: A balancing act. CNS Neuroscience & Therapeutics, 16(3), 163\u2013178.","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"12","key":"8384_CR3","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","volume":"122","author":"TC Andrews","year":"1999","unstructured":"Andrews, T. C., Weeks, R. A., Turjanski, N., Gunn, R. N., Watkins, L. H., Sahakian, B., et al. (1999). Huntington\u2019s disease progression: PET and clinical observations. Brain, 122(12), 2353\u20132363.","journal-title":"Brain"},{"issue":"2","key":"8384_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.410430216","volume":"43","author":"A Antonini","year":"1998","unstructured":"Antonini, A., Leenders, K. L., & Eidelberg, D. (1998). [11C]Raclopride-PET studies of the Huntington\u2019s disease rate of progression: Relevance of the trinucleotide repeat length. Annals of Neurology, 43(2), 253\u2013255.","journal-title":"Annals of Neurology"},{"issue":"6","key":"8384_CR5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jnr.10272","volume":"68","author":"MA Ariano","year":"2002","unstructured":"Ariano, M. A., Aronin, N., Difiglia, M., Tagle, D. A., Sibley, D. R., Leavitt, B. R., et al. (2002). Striatal neurochemical changes in transgenic models of Huntington\u2019s disease. Journal of Neuroscience Research, 68(6), 716\u2013729.","journal-title":"Journal of Neuroscience Research"},{"issue":"1\u20132","key":"8384_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.01.021","volume":"1005","author":"VJ Bolivar","year":"2004","unstructured":"Bolivar, V. J., Manley, K., & Messer, A. (2004). Early exploratory behavior abnormalities in R6\/1 Huntington\u2019s disease transgenic mice. Brain Research, 1005(1\u20132), 29\u201335.","journal-title":"Brain Research"},{"issue":"10","key":"8384_CR7","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1172\/JCI74809","volume":"124","author":"V Brito","year":"2014","unstructured":"Brito, V., Giralt, A., Enriquez-Barreto, L., Puigdell\u00edvol, M., Suelves, N., Zamora-Moratalla, A., et al. (2014). Neurotrophin receptor p75(NTR) mediates Huntington\u2019s disease-associated synaptic and memory dysfunction. The Journal of Clinical Investigation, 124(10), 4411\u20134428.","journal-title":"The Journal of Clinical Investigation"},{"key":"8384_CR8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","volume":"211","author":"C Cepeda","year":"2014","unstructured":"Cepeda, C., Murphy, K. P. S., Parent, M., & Levine, M. S. (2014). The role of dopamine in Huntington\u2019s disease. Progress in Brain Research, 211, 235\u2013254.","journal-title":"Progress in Brain Research"},{"issue":"7","key":"8384_CR9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1460-9568.1992.tb00175.x","volume":"4","author":"M Chritin","year":"1992","unstructured":"Chritin, M., Savasta, M., Mennicken, F., Bal, A., Abrous, D. N., Le Moal, M., et al. (1992). Intrastriatal dopamine-rich implants reverse the increase of dopamine D2 receptor mRNA levels caused by lesion of the nigrostriatal pathway: A quantitative in situ hybridization study. The European Journal of Neuroscience, 4(7), 663\u2013672.","journal-title":"The European Journal of Neuroscience"},{"issue":"9","key":"8384_CR10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.tins.2008.06.008","volume":"31","author":"LL Colgin","year":"2008","unstructured":"Colgin, L. L., Moser, E. I., & Moser, M.-B. (2008). Understanding memory through hippocampal remapping. Trends in Neurosciences, 31(9), 469\u2013477.","journal-title":"Trends in Neurosciences"},{"issue":"19","key":"8384_CR11","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","volume":"15","author":"DM Cummings","year":"2006","unstructured":"Cummings, D. M., Milnerwood, A. J., Dall\u00e9rac, G. M., Waights, V., Brown, J. Y., Vatsavayai, S. C., et al. (2006). Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington\u2019s disease. Human Molecular Genetics, 15(19), 2856\u20132868.","journal-title":"Human Molecular Genetics"},{"key":"8384_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fncel.2013.00159","volume":"7","author":"G Dallerac","year":"2013","unstructured":"Dallerac, G., Chever, O., & Rouach, N. (2013). How do astrocytes shape synaptic transmission? Insights from electrophysiology. Frontiers in Cellular Neuroscience, 7, 159.","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"2","key":"8384_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000375126","volume":"15","author":"GM Dall\u00e9rac","year":"2015","unstructured":"Dall\u00e9rac, G. M., Levasseur, G., Vatsavayai, S. C., Milnerwood, A. J., Cummings, D. M., Kraev, I., et al. (2015). Dysfunctional dopaminergic neurones in mouse models of Huntington\u2019s disease: a role for SK3 channels. Neuro-Degenerative Diseases, 15(2), 93\u2013108.","journal-title":"Neuro-Degenerative Diseases"},{"issue":"4","key":"8384_CR14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000322540","volume":"8","author":"GM Dall\u00e9rac","year":"2011","unstructured":"Dall\u00e9rac, G. M., Vatsavayai, S. C., Cummings, D. M., Milnerwood, A. J., Peddie, C. J., Evans, K. A., et al. (2011). Impaired long-term potentiation in the prefrontal cortex of Huntington\u2019s disease mouse models: rescue by D(1) dopamine receptor activation. Neurodegenerative Diseases, 8(4), 230\u2013239.","journal-title":"Neurodegenerative Diseases"},{"issue":"3","key":"8384_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","volume":"120","author":"N Ginovart","year":"1997","unstructured":"Ginovart, N., Lundin, A., Farde, L., Halldin, C., B\u00e4ckman, L., Swahn, C. G., et al. (1997). PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease. Brain, 120(3), 503\u2013514.","journal-title":"Brain"},{"issue":"3","key":"8384_CR16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","volume":"97","author":"M Glass","year":"2000","unstructured":"Glass, M., Dragunow, M., & Faull, R. L. M. L. (2000). The pattern of neurodegeneration in Huntington\u2019s disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease. Neuroscience, 97(3), 505\u2013519.","journal-title":"Neuroscience"},{"key":"8384_CR17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0079-6123(08)00928-X","volume":"172","author":"I Gonz\u00e1lez-Burgos","year":"2008","unstructured":"Gonz\u00e1lez-Burgos, I., & Feria-Velasco, A. (2008). Serotonin\/dopamine interaction in memory formation. Progress in Brain Research, 172, 603\u2013623.","journal-title":"Progress in Brain Research"},{"issue":"4","key":"8384_CR18","first-page":"845","volume":"24","author":"N Hansen","year":"2014","unstructured":"Hansen, N., & Manahan-Vaughan, D. (2014). Dopamine D1\/D5 receptors mediate informational saliency that promotes persistent hippocampal long-term plasticity. Cerebral Cortex (New York, N.Y.: 1991), 24(4), 845\u2013858.","journal-title":"Cerebral Cortex (New York, N.Y.\u202f: 1991)"},{"key":"8384_CR19","volume-title":"Major problems of neurology","author":"P Harper","year":"1996","unstructured":"Harper, P. (1996). Huntington\u2019s disease. In W. B. Saunders (Ed.), Major problems of neurology (2nd ed.). Philadelphia, PA: WB Saunders.","edition":"2"},{"issue":"34","key":"8384_CR20","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","volume":"27","author":"MY Heng","year":"2007","unstructured":"Heng, M. Y., Tallaksen-Greene, S. J., Detloff, P. J., & Albin, R. L. (2007). Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington\u2019s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 27(34), 8989\u20138998.","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"1","key":"8384_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JGG Hodgson","year":"1999","unstructured":"Hodgson, J. G. G., Agopyan, N., Gutekunst, C.-A. A., Leavitt, B. R., LePiane, F., Singaraja, R., et al. (1999). A YAC mouse model for Huntington\u2019s disease with full-length mutant Huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron, 23(1), 181\u2013192.","journal-title":"Neuron"},{"issue":"9","key":"8384_CR22","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1073\/pnas.0308280101","volume":"101","author":"Y-YY Huang","year":"2004","unstructured":"Huang, Y.-Y. Y., Simpson, E., Kellendonk, C., & Kandel, E. R. (2004). Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors. Proceedings of the National Academy of Sciences of the United States of America, 101(9), 3236\u20133241.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"8384_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0301-0082(03)00085-6","volume":"69","author":"TM Jay","year":"2003","unstructured":"Jay, T. M. (2003). Dopamine: A potential substrate for synaptic plasticity and memory mechanisms. Progress in Neurobiology, 69(6), 375\u2013390.","journal-title":"Progress in Neurobiology"},{"issue":"3","key":"8384_CR24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","volume":"97","author":"MA Johnson","year":"2006","unstructured":"Johnson, M. A., Rajan, V., Miller, C. E., & Wightman, R. M. (2006). Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease. Journal of Neurochemistry, 97(3), 737\u2013746.","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"8384_CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0896-6273(00)80351-7","volume":"19","author":"MA Kelly","year":"1997","unstructured":"Kelly, M. A., Rubinstein, M., Asa, S. L., Zhang, G., Saez, C., Bunzow, J. R., et al. (1997). Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron, 19(1), 103\u2013113.","journal-title":"Neuron"},{"issue":"3","key":"8384_CR26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0166-4328(81)90004-8","volume":"3","author":"GF Koob","year":"1981","unstructured":"Koob, G. F., Stinus, L., & Le Moal, M. (1981). Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Behavioural Brain Research, 3(3), 341\u2013359.","journal-title":"Behavioural Brain Research"},{"issue":"12","key":"8384_CR27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00702-010-0454-z","volume":"117","author":"A Korchounov","year":"2010","unstructured":"Korchounov, A., Meyer, M. F., & Krasnianski, M. (2010). Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation. Journal of Neural Transmission (Vienna, Austria: 1996), 117(12), 1359\u20131369.","journal-title":"Journal of Neural Transmission (Vienna, Austria\u202f: 1996)"},{"issue":"4","key":"8384_CR28","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.neuroscience.2007.03.036","volume":"146","author":"VWS Kung","year":"2007","unstructured":"Kung, V. W. S., Hassam, R., Morton, A. J., & Jones, S. (2007). Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6\/2 mouse model of Huntington\u2019s disease. Neuroscience, 146(4), 1571\u20131580.","journal-title":"Neuroscience"},{"issue":"2","key":"8384_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(89)90617-3","volume":"502","author":"GJ LaHoste","year":"1989","unstructured":"LaHoste, G. J., & Marshall, J. F. (1989). Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: Evidence from quantitative autoradiography indicates a single mechanism of action. Brain Research, 502(2), 223\u2013232.","journal-title":"Brain Research"},{"issue":"5","key":"8384_CR30","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1152\/jn.00308.2004","volume":"92","author":"L Li","year":"2004","unstructured":"Li, L., Murphy, T. H., Hayden, M. R., & Raymond, L. A. (2004). Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease. Journal of Neurophysiology, 92(5), 2738\u20132746.","journal-title":"Journal of Neurophysiology"},{"issue":"16","key":"8384_CR31","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","volume":"27","author":"G Lynch","year":"2007","unstructured":"Lynch, G., Kramar, E. A., Rex, C. S., Jia, Y., Chappas, D., Gall, C. M., & Simmons, D. A. (2007). Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington\u2019s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 27(16), 4424\u20134434.","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"3","key":"8384_CR32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., et al. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87(3), 493\u2013506.","journal-title":"Cell"},{"issue":"1","key":"8384_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2004.04.056","volume":"367","author":"AJ Milner","year":"2004","unstructured":"Milner, A. J., Cummings, D. M., Spencer, J. P., & Murphy, K. P. S. J. (2004). Bi-directional plasticity and age-dependent long-term depression at mouse CA3-CA1 hippocampal synapses. Neuroscience Letters, 367(1), 1\u20135.","journal-title":"Neuroscience Letters"},{"issue":"10","key":"8384_CR34","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","volume":"15","author":"AJ Milnerwood","year":"2006","unstructured":"Milnerwood, A. J., Cummings, D. M., Dallerac, G. M., Brown, J. Y., Vatsavayai, S. C., Hirst, M. C., et al. (2006). Early development of aberrant synaptic plasticity in a mouse model of Huntington\u2019s disease. Human Molecular Genetics, 15(10), 1690\u20131703.","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"8384_CR35","doi-asserted-by":"crossref","first-page":"e18336","DOI":"10.1371\/journal.pone.0018336","volume":"6","author":"F Mochel","year":"2011","unstructured":"Mochel, F., Durant, B., Durr, A., & Schiffmann, R. (2011). Altered dopamine and serotonin metabolism in motorically asymptomatic R6\/2 mice. PLoS ONE, 6(3), e18336.","journal-title":"PLoS ONE"},{"issue":"13","key":"8384_CR36","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KPSJ Murphy","year":"2000","unstructured":"Murphy, K. P. S. J., Carter, R. J., Lione, L. A., Mangiarini, L., Mahal, A., Bates, G. P., et al. (2000). Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation. Journal of Neuroscience, 20(13), 5115\u20135123.","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"8384_CR37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2011.01.036","volume":"492","author":"AN Ortiz","year":"2011","unstructured":"Ortiz, A. N., Kurth, B. J., Osterhaus, G. L., & Johnson, Ma. (2011). Impaired dopamine release and uptake in R6\/1 Huntington\u2019s disease model mice. Neuroscience Letters, 492(1), 11\u201314.","journal-title":"Neuroscience Letters"},{"issue":"1","key":"8384_CR38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","volume":"83","author":"JL Plotkin","year":"2014","unstructured":"Plotkin, J. L., Day, M., Peterson, J. D., Xie, Z., Kress, G. J., Rafalovich, I., et al. (2014). Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington\u2019s disease. Neuron, 83(1), 178\u2013188.","journal-title":"Neuron"},{"issue":"3","key":"8384_CR39","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0306-4522(92)90159-Y","volume":"46","author":"M Savasta","year":"1992","unstructured":"Savasta, M., Mennicken, F., Chritin, M., Abrous, D. N., Feuerstein, C., Le Moal, M., & Herman, J. P. (1992). Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Neuroscience, 46(3), 729\u2013738.","journal-title":"Neuroscience"},{"issue":"10","key":"8384_CR40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tics.2010.08.002","volume":"14","author":"D Shohamy","year":"2010","unstructured":"Shohamy, D., & Adcock, R. A. (2010). Dopamine and adaptive memory. Trends in Cognitive Sciences, 14(10), 464\u2013472.","journal-title":"Trends in Cognitive Sciences"},{"issue":"12","key":"8384_CR41","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","volume":"106","author":"DA Simmons","year":"2009","unstructured":"Simmons, D. A., Rex, C. S., Palmer, L., Pandyarajan, V., Fedulov, V., Gall, C. M., & Lynch, G. (2009). Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington\u2019s disease knockin mice. Proceedings of the National Academy of Sciences of the United States of America, 106(12), 4906\u20134911.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Suppl 3","key":"8384_CR42","doi-asserted-by":"crossref","first-page":"S534","DOI":"10.1002\/mds.22027","volume":"23","author":"Y Smith","year":"2008","unstructured":"Smith, Y., & Villalba, R. (2008). Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Movement Disorders: Official Journal of the Movement Disorder Society, 23(Suppl 3), S534\u2013S547.","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"5","key":"8384_CR43","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","volume":"17","author":"X Tong","year":"2014","unstructured":"Tong, X., Ao, Y., Faas, G. C., Nwaobi, S. E., Xu, J., Haustein, M. D., et al. (2014). Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice. Nature Neuroscience, 17(5), 694\u2013703.","journal-title":"Nature Neuroscience"},{"issue":"5","key":"8384_CR44","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","volume":"8","author":"MT Usdin","year":"1999","unstructured":"Usdin, M. T., Shelbourne, P. F., Myers, R. M., & Madison, D. V. (1999). Impaired synaptic plasticity in mice carrying the Huntington\u2019s disease mutation. Human Molecular Genetics, 8(5), 839\u2013846.","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"8384_CR45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.expneurol.2006.10.014","volume":"204","author":"K Borght van der","year":"2007","unstructured":"van der Borght, K., & Brundin, P. (2007). Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6\/1 and R6\/2 mouse models of Huntington\u2019s disease. Experimental Neurology, 204(1), 473\u2013478.","journal-title":"Experimental Neurology"},{"issue":"2","key":"8384_CR46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-199911020-00003","volume":"11","author":"J Vugt Van","year":"1999","unstructured":"Van Vugt, J., & Roos, R. (1999). Huntington\u2019s disease: Options for controlling symptoms. CNS Drugs, 11(2), 105\u2013123.","journal-title":"CNS Drugs"},{"issue":"9","key":"8384_CR47","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/brain\/120.9.1569","volume":"120","author":"R Weeks","year":"1997","unstructured":"Weeks, R. (1997). Cortical control of movement in Huntington\u2019s disease. A PET activation study. Brain, 120(9), 1569\u20131578.","journal-title":"Brain"},{"key":"8384_CR48","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","volume":"33","author":"MM Zeron","year":"2002","unstructured":"Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., et al. (2002). Increased sensitivity to N-methyl-D-aspartate in a mouse model of Huntington\u2019 s disease. Neuron, 33, 849\u2013860.","journal-title":"Neuron"},{"issue":"1","key":"8384_CR49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., et al. (2003). Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nature Genetics, 35(1), 76\u201383.","journal-title":"Nature Genetics"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-016-8384-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-016-8384-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-016-8384-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T15:36:36Z","timestamp":1567524996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-016-8384-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,18]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["8384"],"URL":"https:\/\/doi.org\/10.1007\/s12017-016-8384-z","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,18]]}}}